Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland.

ROBERT C. BOURGE, MD, FACC ANNETINE GELIJNS, PhD BARTLEY P. GRIFFITH, MD RAY E. HERSHBERGER, MD, FACC SHARON HUNT, MD, FACC JAMES KIRKLIN, MD, FACC LESLIE W. MILLER, MD, FACC WALTER E. PAE, JR., MD, FACC GEORGE PANTALOS, PhD D. GLENN PENNINGTON, MD, FACC ERIC A. ROSE, MD, FACC JOHN T. WATSON, PhD

[1]  M C Oz,et al.  Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. , 1995, Circulation.

[2]  R Hetzer,et al.  Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. , 1999, The Annals of thoracic surgery.

[3]  H. Robbins,et al.  Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal. , 1996, American journal of public health.

[4]  L. Roth,et al.  Ethical factors in the allocation of experimental medical therapies: the chronic left ventricular assist system. , 1990, Clinical research.

[5]  W. Silverman.  Human Experimentation: A Guided Step into the Unknown , 1985 .

[6]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[7]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[8]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[9]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[10]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[11]  Roger B. Davis,et al.  The Last Six Months of Life for Patients with Congestive Heart Failure , 2000, Journal of the American Geriatrics Society.

[12]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[13]  M. Oz,et al.  Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  J. Luck,et al.  A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond , 1998, Journal of cardiovascular electrophysiology.

[15]  Eric J. Topol,et al.  Clinical studyContemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience , 1995 .

[16]  APACHE II score and mortality in respiratory failure due to cardiogenic pulmonary edema. , 1988, Critical care medicine.

[17]  D. Pennington,et al.  Univentricular versus biventricular assist device support. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  A. Katz,et al.  Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle--Part I. , 1997, Journal of cardiac failure.

[19]  T. Paine,et al.  Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events. , 1995, The Journal of thoracic and cardiovascular surgery.

[20]  J. Kirklin,et al.  Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. , 1991, The Journal of thoracic and cardiovascular surgery.

[21]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[22]  J. Parrillo,et al.  The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  O. Frazier,et al.  An atrial hydraulic shunt in a total artificial heart. A balance mechanism for the bronchial shunt. , 1993, ASAIO journal.

[24]  L. Gray,et al.  Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. , 1989, Circulation.

[25]  L. Gray,et al.  Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.

[26]  G Rosenberg,et al.  Long‐Term Mechanical Circulatory Support System Reliability Recommendation American Society for Artificial Internal Organs and Society of Thoracic Surgeons: Long‐Term Mechanical Circulatory Support System Reliability Recommendation , 1998, The Annals of thoracic surgery.

[27]  S. Hunt,et al.  Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  R Jarvik,et al.  Durability testing of components for the Jarvik 2000 completely implantable axial flow left ventricular assist device. , 1998, ASAIO journal.

[29]  L. Miller,et al.  Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  A. Snyder,et al.  Steady state hemodynamic and energetic characterization of the Penn State/3M Health Care Total Artificial Heart. , 1999, ASAIO journal.

[31]  C. Maynard,et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS). , 1983, Circulation.

[32]  M. Oz,et al.  Miniature axial flow pump for ventricular assistance in children and small adults. , 1996, The Journal of thoracic and cardiovascular surgery.

[33]  B. Freedman.  Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[34]  K. McPherson,et al.  Are Randomized Controlled Trials Controlled? Patient Preferences and Unblind Trials , 1997, Journal of the Royal Society of Medicine.

[35]  F. Harrell,et al.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). , 1997, American heart journal.

[36]  D C Naftel,et al.  Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  G. Sutton,et al.  DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE , 1987, The Lancet.

[38]  B G Min,et al.  In vivo performance evaluation of a transcutaneous energy and information transmission system for the total artificial heart. , 1993, ASAIO journal.

[39]  N G Smedira,et al.  Factors influencing HLA sensitization in implantable LVAD recipients. , 1997, The Annals of thoracic surgery.

[40]  M. Lambert,et al.  Incorporating patient preferences into randomized trials. , 2000, Journal of clinical epidemiology.

[41]  W. Baxley,et al.  Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. , 1998, The American journal of cardiology.

[42]  G. Couper,et al.  Target heart failure populations for newer therapies. , 1995, Circulation.

[43]  M. Oz,et al.  Selection criteria for placement of left ventricular assist devices. , 1995, American heart journal.

[44]  G Laufer,et al.  First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. , 2000, Circulation.

[45]  D. Goldhill,et al.  APACHE II, data accuracy and outcome prediction , 1998, Anaesthesia.

[46]  G. D. Roye,et al.  Circulatory support for myocardial infarction with ventricular arrhythmias. , 1995, The Annals of thoracic surgery.

[47]  A. Snyder,et al.  A completely implanted left ventricular assist device. Chronic in vivo testing. , 1993, ASAIO journal.

[48]  N G Smedira,et al.  Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. , 1999, The Annals of thoracic surgery.

[49]  J. Parker,et al.  Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina. , 1996, Circulation.

[50]  O. Howard Frazier,et al.  Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. , 1998, The Annals of thoracic surgery.

[51]  J T Watson,et al.  The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. , 1999, The Annals of thoracic surgery.

[52]  M. Loebe,et al.  The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[53]  K. Naunheim,et al.  Clinical experience with 111 thoratec ventricular assist devices. , 1999, The Annals of thoracic surgery.

[54]  M. Pfisterer,et al.  A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. , 1999, European heart journal.

[55]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[56]  K Butler,et al.  Development of the Nimbus/Pittsburgh axial flow left ventricular assist system. , 1997, Artificial organs.

[57]  Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. , 1993 .

[58]  Poirier Vl,et al.  Worldwide Experience With the TCI HeartMate® System: Issues and Future Perspective , 1999, The Thoracic and cardiovascular surgeon.

[59]  M C Oz,et al.  100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. , 1999, The Annals of thoracic surgery.

[60]  S Hellman,et al.  Of mice but not men. Problems of the randomized clinical trial. , 1991, The New England journal of medicine.

[61]  E. Passamani,et al.  Clinical trials--are they ethical? , 1991, The New England journal of medicine.

[62]  M. Merriman,et al.  Measuring quality of life for patients with terminal illness: the Missoula–VITAS® quality of life index , 1998, Palliative medicine.

[63]  W. Kolff,et al.  Extracorporeal assistance to the circulation and intraaortic balloon pumping. , 1962, Transactions - American Society for Artificial Internal Organs.

[64]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[65]  M. Gheorghiade,et al.  WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .

[66]  B. Griffith,et al.  Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. , 1996, The Journal of thoracic and cardiovascular surgery.

[67]  R. Califf,et al.  Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. , 2000, American heart journal.

[68]  R E Clark,et al.  AB-180 circulatory support system: summary of development and phase I clinical trial. , 1998, ASAIO journal.

[69]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[70]  B. Uretsky,et al.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.

[71]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.

[72]  D. Marquis.  How to resolve an ethical dilemma concerning randomized clinical trials. , 1999, The New England journal of medicine.

[73]  A. Moskowitz,et al.  Quality of life with an implanted left ventricular assist device. , 1997, The Annals of thoracic surgery.

[74]  D. Torgerson,et al.  Understanding controlled trials: What is a patient preference trial? , 1998, BMJ.

[75]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[76]  L. Stevenson,et al.  Heart failure patients express strong polarity of preference for either quality of life or survival , 1998 .

[77]  S J Pocock,et al.  Randomized trials or observational tribulations? , 2000, The New England journal of medicine.

[78]  R. Masters.  Surgical Options for the Treatment of Heart Failure , 1999, Developments in Cardiovascular Medicine.

[79]  R. Bolman,et al.  Management of recurrent ventricular tachycardia with ventricular assist device placement. , 1998, The Annals of thoracic surgery.

[80]  E. Varnauskas.  Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. , 1988, The New England journal of medicine.

[81]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[82]  C. Brewin,et al.  Patient preferences and randomised clinical trials. , 1989, BMJ.

[83]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[84]  A. Jacobs,et al.  Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality Results of an International Registry , 1995 .

[85]  B. Olshansky,et al.  Control of Refractory Ventricular Tachycardia with Biventricular Assist Devices , 1991, Pacing and clinical electrophysiology : PACE.

[86]  M. Oz,et al.  Improved survival rates support left ventricular assist device implantation early after myocardial infarction. , 1998, Journal of the American College of Cardiology.

[87]  S W Lagakos,et al.  Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .

[88]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[89]  T. Takaro,et al.  Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. , 1977, The New England journal of medicine.

[90]  R. Califf,et al.  Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. , 1999, American heart journal.

[91]  M. Kern,et al.  Early ambulation after 5 French diagnostic cardiac catheterization: results of a multicenter trial. , 1990, Journal of the American College of Cardiology.

[92]  A. Katz.  Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart. , 1998, Journal of cardiac failure.

[93]  K E Buck,et al.  Portable Pneumatic Biventricular Driver for the Thoratec Ventricular Assist Device , 1997, ASAIO journal.